BLISS GVS PHARMA
Back to Cashflow Statement
|
BLISS GVS PHARMA Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹11 Cr | ₹0.13 Cr | ₹-1.27 Cr | ₹1.62 Cr | ₹19 Cr |
What is the latest Net Cash Inflow / Outflow ratio of BLISS GVS PHARMA ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2026 | ₹11 Cr |
| Mar2025 | ₹0.13 Cr |
| Mar2024 | ₹-1.27 Cr |
| Mar2023 | ₹1.62 Cr |
| Mar2022 | ₹19 Cr |
How is Net Cash Inflow / Outflow of BLISS GVS PHARMA Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2026 | ₹11 Cr | 8,740.94 | |
| Mar2025 | ₹0.13 Cr | Positive | |
| Mar2024 | ₹-1.27 Cr | Negative | |
| Mar2023 | ₹1.62 Cr | -91.35 | |
| Mar2022 | ₹19 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of BLISS GVS PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BLISS GVS PHARMA | ₹4,963.8 Cr | 1.4% | -11.2% | 197% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹477,312.0 Cr | 0.8% | 6.3% | 18.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹213,879.0 Cr | 8.6% | 20.7% | 18.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹194,094.0 Cr | 1.7% | 9.4% | 38.5% | Stock Analytics | |
| CIPLA | ₹118,992.0 Cr | 4.5% | 1.2% | -1.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹95,787.4 Cr | -0.3% | -14.8% | -9.5% | Stock Analytics | |
BLISS GVS PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BLISS GVS PHARMA | 1.4% |
-11.2% |
197% |
| SENSEX | 2.7% |
1.5% |
-5.6% |
You may also like the below Video Courses